infigratinib for cca
Published 4 years ago • 383 plays • Length 7:27Download video MP4
Download video MP3
Similar videos
-
9:55
fgfr inhibitors in development for cca
-
10:24
proof 301: infigratinib versus gemcitabine plus cisplatin for cca with fgfr2 rearrangements
-
1:45
proof 301: infigratinib in advanced cca
-
4:03
fgfr inhibitors for cca & bladder cancer
-
6:16
proof 301: infigratinib vs. gem/cis in patients with cca with an fgfr2 gene fusion/rearrangement
-
1:15
infigratinib in previously treated advanced cca
-
8:00
claridhy phase iii trial of ivosidenib in cca
-
1:16
dr. abou-alfa on remaining questions with infigratinib in fgfr2 cholangiocarcinoma
-
13:33
facebook live: case conference july '22
-
11:51
angio-ct: a breakthrough solution in interventional oncology
-
1:48:14
[complex pci 2023] live case 2: left main & bifurcation
-
1:00:01
webinar: targeting the fgfr pathway: infigratinib in cholangiocarcinoma
-
2:17
dr. roychowdhury on fgfr inhibitor infigratinib in cholangiocarcinoma
-
4:28
proof: infigratinib as first-line therapy in patients with advanced cca
-
10:39
ac22 - explore signaling pathways and combination therapy in fgfr2-activated cholangiocarcinoma
-
2:40
fight-202: pemigatinib for fgfr2 altered cca
-
7:31
fgfr inhibition in advanced cca
-
30:12
2018 cholangiocarcinoma foundation annual conference #10 - day 2 - fgfr signaling
-
2:01
fgfr mutations
-
4:12
fgfr2 inhibitors in advanced cholangiocarcinoma
-
2:12
dr harding on the rationale for targeting fgfr2 in cholangiocarcinoma and biliary tract cancer
-
12:22
bridging therapy with tenecteplase or alteplase in patients with large ischemic core